Abbott Laboratories Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

XTRA:ABL Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
04 Sep 24	Sell€2,798	John McCoy	Individual	27	€103.62
07 May 24	Sell€2,252,566	Lisa Earnhardt	Individual	22,852	€98.57
01 Mar 24	Sell€93,368	Hubert Allen	Individual	853	€109.46
01 Mar 24	Sell€75,964	Lisa Earnhardt	Individual	694	€109.46
01 Mar 24	Sell€51,664	John McCoy	Individual	472	€109.46
01 Mar 24	Sell€73,994	Mary Moreland	Individual	676	€109.46
01 Mar 24	Sell€87,676	Louis Morrone	Individual	801	€109.46
01 Mar 24	Sell€105,408	Daniel Salvadori	Individual	963	€109.46

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ABL?
Owner Type	Number of Shares	Ownership Percentage
State or Government	1,755,917	0.101%
Individual Insiders	8,079,799	0.466%
General Public	383,991,616	22.1%
Institutions	1,340,627,881	77.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 47.48% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.68%	The Vanguard Group, Inc.	167,906,137	€18.1b	0.93%	0.27%
7.55%	BlackRock, Inc.	131,027,791	€14.1b	-0.08%	0.23%
7.08%	Capital Research and Management Company	122,789,437	€13.2b	-6.58%	0.64%
4.42%	State Street Global Advisors, Inc.	76,720,429	€8.3b	3.12%	0.31%
2.01%	Geode Capital Management, LLC	34,903,198	€3.8b	1.42%	0.27%
1.49%	Wellington Management Group LLP	25,810,977	€2.8b	1.1%	0.45%
1.29%	JP Morgan Asset Management	22,304,613	€2.4b	131%	0.27%
1.17%	Norges Bank Investment Management	20,356,932	€2.2b	0%	0.18%
1.15%	Northern Trust Global Investments	19,996,210	€2.2b	-3.3%	0.33%
1.02%	UBS Asset Management AG	17,674,029	€1.9b	2.3%	0.19%
0.89%	Wells Fargo & Company, Securities and Brokerage Investments	15,359,180	€1.7b	0.28%	0.51%
0.82%	Legal & General Investment Management Limited	14,258,807	€1.5b	-0.62%	0.28%
0.8%	Polen Capital Management, LLC	13,939,823	€1.5b	-8.94%	3.69%
0.78%	State Farm Insurance Companies, Asset Management Arm	13,587,118	€1.5b	0%	1.34%
0.77%	BNY Asset Management	13,337,378	€1.4b	-4.3%	0.28%
0.77%	Massachusetts Financial Services Company	13,319,347	€1.4b	25.6%	0.32%
0.73%	Charles Schwab Investment Management, Inc.	12,624,697	€1.4b	-0.09%	0.23%
0.72%	Morgan Stanley Investment Management Inc.	12,560,607	€1.4b	-5.07%	1.07%
0.7%	Columbia Management Investment Advisers, LLC	12,084,392	€1.3b	13.2%	0.3%
0.64%	Fisher Asset Management, LLC	11,102,204	€1.2b	5.57%	0.49%
0.64%	Morgan Stanley, Investment Banking and Brokerage Investments	11,030,440	€1.2b	-5.34%	0.14%
0.63%	Deutsche Asset & Wealth Management	10,982,996	€1.2b	9.07%	0.34%
0.63%	Eaton Vance Management	10,914,684	€1.2b	2.05%	0.28%
0.55%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	9,479,193	€1.0b	3.39%	0.25%
0.54%	Morgan Stanley Investment Management Limited	9,439,508	€1.0b	-0.34%	2.46%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 21:53
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Abbott Laboratories is covered by 61 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
David Toung	Argus Research Company
Stephan Gasteyger	Atlantic Equities LLP
Ishan Majumdar	Baptista Research